Change In Sexual Function In Men With LUTS/BPH Associated With Long-Term Treatment With Doxazosin, Finasteride, And Combined Therapy
March 2014
in “
The Journal of Urology
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This study observed that long-term treatment with 5ARIs in men with LUTS/BPH was linked to worsening sexual function, whereas doxazosin alone had minimal negative impact.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study assessed the impact of long-term treatment with doxazosin, finasteride, and combined therapy on sexual function in men with lower urinary tract symptoms (LUTS) using data from the MTOPS trial, which included 2,783 men. Results indicated that men taking 5-alpha-reductase inhibitors (5ARIs) experienced significant declines in ejaculatory function, while those on combined therapy also saw declines in erectile function and sexual problem assessment. In contrast, doxazosin alone did not significantly affect sexual function compared to placebo. The study highlighted the importance of discussing potential long-term negative effects of LUTS drug treatments on sexual function with patients.
